Welcome to the world of facts and news: US investor Janus Henderson cut PharmEasy valuation by half to $2.8 billion

US investor Janus Henderson cut PharmEasy valuation by half to $2.8 billion

The global investor, which picked a stake in PharmEasy in September 2021, has reduced the valuation of its holding in the firm by half, which would translate to an approximate valuation of around $2.8 billion as of December 31, 2022.

from Tech-Economic Times https://ift.tt/1XatKcU
By -
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Yellow.ai deploys 30% of global generative AI bots domestically

While markets like the US are mostly using GenAI for customer support in a bid to cut costs, India Inc. is using them as an opportunity to g...